Indraprastha Medical Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Indraprastha Medical.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 26.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06
Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention
Nov 03We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00
Sep 10Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year
Aug 08Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
Jul 31Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Jan 21We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve
Nov 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Nov 02Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
May 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Jun 10Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year
Feb 21In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Indraprastha Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 12,040 | 1,126 | N/A | N/A | N/A |
| 9/30/2023 | 11,745 | 1,041 | 447 | 1,084 | N/A |
| 6/30/2023 | 11,419 | 964 | N/A | N/A | N/A |
| 3/31/2023 | 10,987 | 862 | 999 | 1,445 | N/A |
| 12/31/2022 | 10,411 | 815 | N/A | N/A | N/A |
| 9/30/2022 | 10,000 | 765 | 1,133 | 1,432 | N/A |
| 6/30/2022 | 9,486 | 635 | N/A | N/A | N/A |
| 3/31/2022 | 8,882 | 586 | 648 | 943 | N/A |
| 12/31/2021 | 8,705 | 585 | N/A | N/A | N/A |
| 9/30/2021 | 8,139 | 546 | 726 | 974 | N/A |
| 6/30/2021 | 7,221 | 430 | N/A | N/A | N/A |
| 3/31/2021 | 6,134 | 23 | 59 | 268 | N/A |
| 12/31/2020 | 6,158 | -63 | N/A | N/A | N/A |
| 9/30/2020 | 6,462 | -76 | 417 | 632 | N/A |
| 6/30/2020 | 7,213 | 99 | N/A | N/A | N/A |
| 3/31/2020 | 8,308 | 436 | 455 | 865 | N/A |
| 12/31/2019 | 8,307 | 443 | N/A | N/A | N/A |
| 9/30/2019 | 8,185 | 407 | N/A | N/A | N/A |
| 6/30/2019 | 8,025 | 305 | N/A | N/A | N/A |
| 3/31/2019 | 7,882 | 284 | 581 | 752 | N/A |
| 12/31/2018 | 7,734 | 269 | N/A | N/A | N/A |
| 9/30/2018 | 7,610 | 253 | N/A | N/A | N/A |
| 6/30/2018 | 7,527 | 228 | N/A | N/A | N/A |
| 3/31/2018 | 7,527 | 211 | 170 | 477 | N/A |
| 12/31/2017 | 7,471 | 202 | N/A | N/A | N/A |
| 9/30/2017 | 7,537 | 207 | N/A | N/A | N/A |
| 6/30/2017 | 7,564 | 228 | N/A | N/A | N/A |
| 3/31/2017 | 7,657 | 262 | N/A | 276 | N/A |
| 12/31/2016 | 7,660 | 304 | N/A | N/A | N/A |
| 9/30/2016 | 7,635 | 283 | N/A | N/A | N/A |
| 6/30/2016 | 7,640 | 296 | N/A | N/A | N/A |
| 3/31/2016 | 7,554 | 244 | N/A | 623 | N/A |
| 12/31/2015 | 7,472 | 303 | N/A | N/A | N/A |
| 9/30/2015 | 7,340 | 323 | N/A | N/A | N/A |
| 6/30/2015 | 7,226 | 321 | N/A | N/A | N/A |
| 3/31/2015 | 7,145 | 325 | N/A | 643 | N/A |
| 12/31/2014 | 7,016 | 321 | N/A | N/A | N/A |
| 9/30/2014 | 6,949 | 331 | N/A | N/A | N/A |
| 6/30/2014 | 6,897 | 342 | N/A | N/A | N/A |
| 3/31/2014 | 6,776 | 354 | N/A | 581 | N/A |
| 12/31/2013 | 6,663 | 347 | N/A | N/A | N/A |
| 9/30/2013 | 6,490 | 334 | N/A | N/A | N/A |
| 6/30/2013 | 6,080 | 303 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if INDRAMEDCO's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if INDRAMEDCO's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if INDRAMEDCO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if INDRAMEDCO's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if INDRAMEDCO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if INDRAMEDCO's Return on Equity is forecast to be high in 3 years time